Severe hypertriglyceridemia in a neonate with apolipoprotein A deficiency

Published On: 01 May, 2023 10:42 AM | Updated On: 18 May, 2024 1:34 PM

Severe hypertriglyceridemia in a neonate with apolipoprotein A deficiency

A report describes a case of a 2-day-old male neonate born to consanguineous parents who presented with yellowish skin. The mother suffered moderate hypertriglyceridemia. No other siblings had a history of any chronic diseases. 

General inspection revealed no significant findings. The vital signs, Cardiac, and chest examinations were all normal. Testing for jaundice revealed neonatal jaundice as the cause of yellow skin discoloration, which needed no treatment apart from follow-up. However, blood examination revealed his blood to be milky; hence, a blood lipid profile test was conducted, which showed highly elevated triglyceride levels in multiple checkups, high very-low-density lipoprotein level, high level of low-density lipoprotein, and a low level of high-density lipoprotein.

Additional laboratory diagnosis demonstrated apolipoprotein A1 deficiency and a normal level of apolipoprotein B. The patient remained under close monitoring and received a statin tablet of 0.25 mg twice daily, a formula diet (Monogen – Nutricia) with low triglycerides and rich in medium-chain triglycerides (MCT), and 1 ml Omega-3 syrup twice daily. After this, he dramatically responded as serum triglyceride dropped to 175 mg/dl. The patient then received a 50% MCT formula and Gemfibrozil (a triglyceride-lowering agent). He showed no symptoms in the first two months of his life, apart from an upper respiratory tract flu-like illness. On a 9-month follow-up, the patient normally thrived and had good feeding and typical developmental milestones.

Mohammed BA, Hasan KM, Najmadden ZB, et al. Successful management of severe hypertriglyceridemia in a neonate with apolipoprotein A deficiency; a case report with literature review. Barw Medical Journal. 2023;1(1). doi: 10.58742/bmj.v1i1.16.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks